Invasion of metastatic human follicular thyroid cancer is inhibited via antagonism of protein kinase C

Cancer Letters

Volumn 119, Issue 1, 1997, Pages 1-5

  Hoelting, Thomas ^a   Duh, Quan Yang ^b   Clark, Orlo H ^c   Herfarth, Christian ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Protein kinase C; Signal transduction; Thyroid cancer

Indexed keywords

CALPHOSTIN C; CHELERYTHRINE; EPIDERMAL GROWTH FACTOR; PROTEIN KINASE C; STAUROSPORINE;

ARTICLE; CANCER INVASION; ENZYME INHIBITION; HUMAN; HUMAN CELL; METASTASIS; PRIORITY JOURNAL; THYROID FOLLICULAR CARCINOMA;

BENZOPHENANTHRIDINES; CELL LINE, TUMOR; ENZYME INHIBITORS; HUMANS; NAPHTHALENES; NEOPLASM INVASIVENESS; PROTEIN KINASE C; SIGNAL TRANSDUCTION; STAUROSPORINE; TETRADECANOYLPHORBOL ACETATE; THYROID NEOPLASMS; THYROTROPIN;

EID: 0030713065     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(97)00242-5     Document Type: Article

References (20)

1. R. Gopalakrishna, S.H. Barsky, Tumor promoter-induced membrane-bound protein kinase C regulates hematogenous metastases, Proc. Natl. Acad. Sci. USA 85 (1988) 612-616.
2. R.D. Bonfil, S. Momiki, R. Fridman, R. Reich, R. Reddel, C.C. Harris, A. Klein-Szanto, Enhancement of the invasive ability of a transformed human bronchial epithelial cell line by 12-O-tetra-decanoyl-phorbol-13-acetate and diacylglycerol, Carcinogenesis 10 (1989) 2335-2339.
3. M.J. Kennedy, L.J. Prestigiacomo, G. Tyler, W.S. May, N.E. Davidson, Differential effects of bryostatin 1 and phorbol ester on human breast cancer cell lines, Cancer Res. 52 (1992) 1278-1283.
4. S.J. Chmura, E. Nodzenski, R.R. Weichselbaum, J. Quintas, Protein kinase C inhibition induces apoptosis and ceramide production through activation of a neutral sphing-omyelinase. Cancer Res. 56 (1996) 2711-2714.
5. J. Ginsberg, P.G. Murray, Phorbol ester and phospholipase C-mediated differentiated thyroid function in vitro: the effects of protein kinase C inhibition and downregulation, Thyroid 1 (1991) 195-201.
6. C.M. Seynaeve, M. Stetler-Stevenson, S. Sebers, G. Kaur, E.A. Sausville, P.J. Worland, Cell cycle arrest and growth inhibition by the protein kinase antagonist UCN-01 in human breast carcinoma cells, Cancer Res. 53 (1993) 2081-2087.
7. D. Wynford-Thomas, P. Smith, E.D. Williams, Proliferative response to cyclic AMP elevation of thyroid epithelium in suspension culture, Mol. Cell. Endocrinol. 51 (1987) 163-168.
8. T. Hoelting, S. Tezelman, A.E. Siperstein, Q.Y. Dun, O.H. Clark, Thyrotropin stimulates invasion and growth of follicular thyroid cancer cells via PKC-rather than PKA-activation, Biochem. Biophys. Res. Commun. 195 (1993) 1230-1234.
9. M.J. Demeure, C.H. Damsky, F. Elfman, P.E. Goretzki, M.G. Wong, O.H. Clark, Invasion by cultured human follicular thyroid cancer correlates with increased betal integrins and production of proteases, World J. Surg. 16 (1992) 770-776.
10. F.S. Ambiosi-Impiombato, L.A.M. Parks, H.G. Coon, Culture of hormone-dependent functional epithelial cells from rat thyroids, Proc. Natl. Acad. Sci. USA 77 (1980) 3455-3459.
11. T. Hoelting, A. Zielke, A.E. Siperstein, O.H. Clark, Q.Y. Duh, Transforming growth factor beta 1 is a negative regulator for differentiated thyroid cancer: studies of growth, migration, invasion, and adhesion in follicular and papillary thyroid cancer cell lines, J. Clin. Endocrinol. Metab. 79 (1994) 806-813.
12. O.H. Clark, A.E. Siperstein, R. Miller, Receptors and receptor-transducing systems in normal and neoplastic human thyroid tissue, in: P.E. Goretzki, H.D. Roeher (Eds.), Front Horm Res Karger, Basel, 1989, pp. 14-22.
13. A.E. Siperstein, Q.H. Zeng, E.T. Gum, O.H. Clark, Adenylate cyclase activity as a predictor of thyroid tumor aggressiveness, World J. Surg. 12 (1988) 528-533.
14. A.E. Siperstein, H. van Raavenswaay-Claasen, R. Miller, O.H. Clark, Thyroid-stimulating hormone growth-responsive, cyclic adenosine monophosphate-unresponsive poorly differentiated thyroid carcinoma of follicular cell origin, in: P.E. Goretzki, H.D. Roeher (Eds.), Front Horm Res Karger, Basel, 1989, pp. 81-87.
15. P.E. Goretzki, R. Koob, C. Koller, H.D. Roeher, Thyrotropin (TSH) stimulates cell growth and DNA synthesis in monolayer cultures of human thyrocytes independent of the adenylate-cyclase system, Acta Endocrinol. 281 (1987) 273-278.
16. W.H. Dere, H. Hirayu, B. Rapoport, TSH and cAMP enhance expression of the myc proto-oncogene in cultured thyroid cells, Endocrinology 117 (1985) 2249-2254.
17. S.J. Chmura, E. Nodzenski, R.R. Weichselbaum, J. Quintans, Protein kinase C induces apoptosis and ceramide production through activation of a neutral sphingomyelinase, Cancer Res. 56 (1996) 2711-2716.
18. T. Hoelting, O.H. Clark, Q.Y. Duh, Tamoxifen inhibits growth, migration and invasion of human follicular and papillary thyroid cancer cells in vitro and in vivo, J. Clin. Endocrinol. Metab. 80 (1995) 308-314.
19. T. Hoelting, Q.Y. Duh, O.H. Clark, C. Herfarth, Tamoxifen antagonizes proliferation and invasion of estrogen receptornegative metastatic follicular thyroid cancer cells via protein kinase C, Cancer Lett. 100 (1996) 89-94.
20. C.A. O'Brian, N.E. Ward, B.W. Anderson, Role of specific interactions between protein kinase C and triphenylethylenes in inhibition of the enzyme, J. Natl. Cancer Inst. 80 (1988) 1628-1632.